Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Höög A[au]:

Search results

Items: 1 to 50 of 155

1.
2.

MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.

Kumar S, Xie H, Scicluna P, Lee L, Björnhagen V, Höög A, Larsson C, Lui WO.

Cancers (Basel). 2018 Nov 14;10(11). pii: E443. doi: 10.3390/cancers10110443.

3.

The global need for essential emergency and critical care.

Schell CO, Gerdin Wärnberg M, Hvarfner A, Höög A, Baker U, Castegren M, Baker T.

Crit Care. 2018 Oct 29;22(1):284. doi: 10.1186/s13054-018-2219-2.

4.

Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.

Juhlin CC, Bränström R, Shabo I, Höög A.

Int J Surg Pathol. 2018 Oct 29:1066896918809490. doi: 10.1177/1066896918809490. [Epub ahead of print]

PMID:
30370813
5.

Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus.

Appelgren D, Dahle C, Knopf J, Bilyy R, Vovk V, Sundgren PC, Bengtsson AA, Wetterö J, Muñoz LE, Herrmann M, Höög A, Sjöwall C.

Autoimmunity. 2018 Sep;51(6):310-318. doi: 10.1080/08916934.2018.1514496. Epub 2018 Oct 28.

PMID:
30369267
6.

Solid Cell Nests Within a Parathyroid Gland-Report of an Exceptional Case.

Juhlin CC, Nilsson IL, Höög A.

Endocr Pathol. 2018 Dec;29(4):365-368. doi: 10.1007/s12022-018-9539-2.

7.

Somatostatin Receptor Expression in Renal Cell Carcinoma-A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma.

Höög A, Kjellman M, Mattsson P, Juhlin CC, Shabo I.

Clin Genitourin Cancer. 2018 Jun;16(3):e517-e520. doi: 10.1016/j.clgc.2018.03.011. Epub 2018 Mar 27. No abstract available.

PMID:
29656940
8.

Molecular profiles of oxyphilic and chief cell parathyroid adenoma.

Lu M, Kjellin H, Fotouhi O, Lee L, Nilsson IL, Haglund F, Höög A, Lehtiö J, Larsson C.

Mol Cell Endocrinol. 2018 Jul 15;470:84-95. doi: 10.1016/j.mce.2017.10.001. Epub 2017 Oct 3.

9.

Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.

Khaparde S, Raizada N, Nair SA, Denkinger C, Sachdeva KS, Paramasivan CN, Salhotra VS, Vassall A, Hoog AV.

PLoS One. 2017 Sep 7;12(9):e0184270. doi: 10.1371/journal.pone.0184270. eCollection 2017.

10.

Inflammatory infiltrates in parathyroid tumors.

Haglund F, Hallström BM, Nilsson IL, Höög A, Juhlin CC, Larsson C.

Eur J Endocrinol. 2017 Dec;177(6):445-453. doi: 10.1530/EJE-17-0277. Epub 2017 Aug 30.

11.

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.

Ssempijja V, Nakigozi G, Chang L, Gray R, Wawer M, Ndyanabo A, Kasule J, Serwadda D, Castelnuovo B, Hoog AV, Reynolds SJ.

BMC Infect Dis. 2017 Aug 22;17(1):582. doi: 10.1186/s12879-017-2680-6.

12.

Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.

Rupert S, Vassall A, Raizada N, Khaparde SD, Boehme C, Salhotra VS, Sachdeva KS, Nair SA, Hoog AH.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):375-380. doi: 10.5588/ijtld.16.0496.

13.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

Fotouhi O, Kjellin H, Larsson C, Hashemi J, Barriuso J, Juhlin CC, Lu M, Höög A, Pastrián LG, Lamarca A, Soto VH, Zedenius J, Mendiola M, Lehtiö J, Kjellman M.

J Clin Endocrinol Metab. 2016 Oct;101(10):3616-3627. Epub 2016 Jul 26.

14.

Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.

Haglund F, Garvin S, Ihre-Lundgren C, Nilsson IL, Hall E, Carling T, Höög A, Juhlin CC.

Endocr Pathol. 2016 Dec;27(4):346-351.

PMID:
27251056
15.

Diffuse parathyroid hormone expression in parathyroid tumors argues against important functional tumor subclones.

Haglund F, Juhlin CC, Kiss NB, Larsson C, Nilsson IL, Höög A.

Eur J Endocrinol. 2016 May;174(5):583-90. doi: 10.1530/EJE-15-1062. Epub 2016 Feb 10.

16.

Minimally invasive follicular thyroid carcinomas: prognostic factors.

Stenson G, Nilsson IL, Mu N, Larsson C, Lundgren CI, Juhlin CC, Höög A, Zedenius J.

Endocrine. 2016 Aug;53(2):505-11. doi: 10.1007/s12020-016-0876-y. Epub 2016 Feb 8.

17.

Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions.

Dinets A, Pernemalm M, Kjellin H, Sviatoha V, Sofiadis A, Juhlin CC, Zedenius J, Larsson C, Lehtiö J, Höög A.

PLoS One. 2015 May 15;10(5):e0126472. doi: 10.1371/journal.pone.0126472. eCollection 2015.

18.

Prevalence of tuberculosis in adolescents, western Kenya: implications for control programs.

Nduba V, Hoog AH, Mitchell E, Onyango P, Laserson K, Borgdorff M.

Int J Infect Dis. 2015 Jun;35:11-7. doi: 10.1016/j.ijid.2015.03.008. Epub 2015 Mar 12.

19.

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight.

Haglund F, Rosin G, Nilsson IL, Juhlin CC, Pernow Y, Norenstedt S, Dinets A, Larsson C, Hartman J, Höög A.

Endocr Connect. 2015 Mar;4(1):76-85. doi: 10.1530/EC-14-0109. Epub 2015 Feb 3.

20.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Kunstman JW, Juhlin CC, Goh G, Brown TC, Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams C, Mane S, Rimm DL, Prasad ML, Höög A, Zedenius J, Larsson C, Korah R, Lifton RP, Carling T.

Hum Mol Genet. 2015 Apr 15;24(8):2318-29. doi: 10.1093/hmg/ddu749. Epub 2015 Jan 9.

21.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Juhlin CC, Goh G, Healy JM, Fonseca AL, Scholl UI, Stenman A, Kunstman JW, Brown TC, Overton JD, Mane SM, Nelson-Williams C, Bäckdahl M, Suttorp AC, Haase M, Choi M, Schlessinger J, Rimm DL, Höög A, Prasad ML, Korah R, Larsson C, Lifton RP, Carling T.

J Clin Endocrinol Metab. 2015 Mar;100(3):E493-502. doi: 10.1210/jc.2014-3282. Epub 2014 Dec 9.

22.

Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy.

Volpe C, Hamberger B, Höög A, Mukai K, Calissendorff J, Wahrenberg H, Zedenius J, Thorén M.

Clin Endocrinol (Oxf). 2015 May;82(5):639-47. doi: 10.1111/cen.12645. Epub 2014 Dec 19.

PMID:
25347939
23.

TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma.

Xie H, Liu T, Wang N, Björnhagen V, Höög A, Larsson C, Lui WO, Xu D.

Oncotarget. 2014 Oct 30;5(20):10048-57.

24.

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.

Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A.

Clin Cancer Res. 2014 Nov 15;20(22):5733-44. doi: 10.1158/1078-0432.CCR-14-0291. Epub 2014 Sep 11.

25.

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.

Wang N, Liu T, Sofiadis A, Juhlin CC, Zedenius J, Höög A, Larsson C, Xu D.

Cancer. 2014 Oct 1;120(19):2965-79. doi: 10.1002/cncr.28800. Epub 2014 Jun 4.

26.

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.

Fotouhi O, Adel Fahmideh M, Kjellman M, Sulaiman L, Höög A, Zedenius J, Hashemi J, Larsson C.

Epigenetics. 2014 Jul;9(7):987-97. doi: 10.4161/epi.28936. Epub 2014 Apr 24.

27.

Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.

Wang N, Xu D, Sofiadis A, Höög A, Vukojević V, Bäckdahl M, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1571-9. doi: 10.1210/jc.2014-1158. Epub 2014 Apr 23.

28.

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.

Welander J, Andreasson A, Juhlin CC, Wiseman RW, Bäckdahl M, Höög A, Larsson C, Gimm O, Söderkvist P.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1352-60. doi: 10.1210/jc.2013-4375. Epub 2014 Apr 2.

29.

Differentially expressed proteins in malignant and benign adrenocortical tumors.

Kjellin H, Johansson H, Höög A, Lehtiö J, Jakobsson PJ, Kjellman M.

PLoS One. 2014 Feb 3;9(2):e87951. doi: 10.1371/journal.pone.0087951. eCollection 2014.

30.

Long-term storage of endocrine tissues at - 80°C does not adversely affect RNA quality or overall histomorphology.

Andreasson A, Kiss NB, Juhlin CC, Höög A.

Biopreserv Biobank. 2013 Dec;11(6):366-70.

31.

MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.

Velázquez-Fernández D, Caramuta S, Özata DM, Lu M, Höög A, Bäckdahl M, Larsson C, Lui WO, Zedenius J.

Eur J Endocrinol. 2014 Mar 8;170(4):583-91. doi: 10.1530/EJE-13-0817. Print 2014 Apr.

PMID:
24446485
32.

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.

Hashemi J, Fotouhi O, Sulaiman L, Kjellman M, Höög A, Zedenius J, Larsson C.

BMC Cancer. 2013 Oct 29;13:505. doi: 10.1186/1471-2407-13-505.

33.

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Andreasson A, Kiss NB, Caramuta S, Sulaiman L, Svahn F, Bäckdahl M, Höög A, Juhlin CC, Larsson C.

Epigenetics. 2013 Dec;8(12):1347-54. doi: 10.4161/epi.26686. Epub 2013 Oct 22.

34.

MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.

Xie H, Lee L, Caramuta S, Höög A, Browaldh N, Björnhagen V, Larsson C, Lui WO.

J Invest Dermatol. 2014 Feb;134(2):507-517. doi: 10.1038/jid.2013.355. Epub 2013 Aug 20.

35.

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.

Caramuta S, Lee L, Ozata DM, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui WO.

Endocr Relat Cancer. 2013 Jul 4;20(4):551-64. doi: 10.1530/ERC-13-0098. Print 2013 Aug.

36.

Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism.

Volpe C, Höög A, Ogishima T, Mukai K, Lu M, Thorén M, Hamberger B.

J Clin Pathol. 2013 Apr;66(4):351-4. doi: 10.1136/jclinpath-2012-201287. Epub 2013 Feb 22.

PMID:
23436930
37.

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Kiss NB, Muth A, Andreasson A, Juhlin CC, Geli J, Bäckdahl M, Höög A, Wängberg B, Nilsson O, Ahlman H, Larsson C.

Endocr Relat Cancer. 2013 Feb 18;20(1):65-78. doi: 10.1530/ERC-12-0267. Print 2013 Feb.

38.

Mortality trends from 2003 to 2009 among adolescents and young adults in rural Western Kenya using a health and demographic surveillance system.

Phillips-Howard PA, Odhiambo FO, Hamel M, Adazu K, Ackers M, van Eijk AM, Orimba V, Hoog Av, Beynon C, Vulule J, Bellis MA, Slutsker L, deCock K, Breiman R, Laserson KF.

PLoS One. 2012;7(11):e47017. doi: 10.1371/journal.pone.0047017. Epub 2012 Nov 5.

39.

Evidence of a functional estrogen receptor in parathyroid adenomas.

Haglund F, Ma R, Huss M, Sulaiman L, Lu M, Nilsson IL, Höög A, Juhlin CC, Hartman J, Larsson C.

J Clin Endocrinol Metab. 2012 Dec;97(12):4631-9. doi: 10.1210/jc.2012-2484. Epub 2012 Sep 28.

PMID:
23024189
40.

Galanin and its three receptors in human pituitary adenoma.

Tofighi R, Barde S, Palkovits M, Höög A, Hökfelt T, Ceccatelli S, Hulting AL.

Neuropeptides. 2012 Oct;46(5):195-201. doi: 10.1016/j.npep.2012.07.003. Epub 2012 Aug 11.

PMID:
22889491
41.

Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.

Segerhammar I, Larsson C, Nilsson IL, Bäckdahl M, Höög A, Wallin G, Foukakis T, Zedenius J.

J Surg Oncol. 2012 Dec;106(8):981-6. doi: 10.1002/jso.23177. Epub 2012 Jun 4.

PMID:
22674491
42.

Prolactin receptor in primary hyperparathyroidism--expression, functionality and clinical correlations.

Haglund F, Lu M, Vukojević V, Nilsson IL, Andreasson A, Džabić M, Bränström R, Höög A, Juhlin CC, Larsson C.

PLoS One. 2012;7(5):e36448. doi: 10.1371/journal.pone.0036448. Epub 2012 May 11.

43.

Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.

Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J.

Eur J Endocrinol. 2012 Jun;166(6):1049-60. doi: 10.1530/EJE-12-0144. Epub 2012 Mar 28.

44.

Genetic characterization of large parathyroid adenomas.

Sulaiman L, Nilsson IL, Juhlin CC, Haglund F, Höög A, Larsson C, Hashemi J.

Endocr Relat Cancer. 2012 May 24;19(3):389-407. doi: 10.1530/ERC-11-0140. Print 2012 Jun.

45.

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.

Andreasson A, Sulaiman L, do Vale S, Martins JM, Ferreira F, Miltenberger-Miltenyi G, Batista L, Haglund F, Björck E, Nilsson IL, Höög A, Larsson C, Juhlin CC.

Fam Cancer. 2012 Sep;11(3):355-62. doi: 10.1007/s10689-012-9520-z.

PMID:
22395475
46.

High sensitivity of chest radiograph reading by clinical officers in a tuberculosis prevalence survey.

Hoog AH, Meme HK, van Deutekom H, Mithika AM, Olunga C, Onyino F, Borgdorff MW.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1308-14. doi: 10.5588/ijtld.11.0004.

PMID:
22283886
47.

Proteomic profiling of follicular and papillary thyroid tumors.

Sofiadis A, Becker S, Hellman U, Hultin-Rosenberg L, Dinets A, Hulchiy M, Zedenius J, Wallin G, Foukakis T, Höög A, Auer G, Lehtiö J, Larsson C.

Eur J Endocrinol. 2012 Apr;166(4):657-67. doi: 10.1530/EJE-11-0856. Epub 2012 Jan 24.

48.

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.

Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui WO.

Endocr Relat Cancer. 2011 Oct 27;18(6):643-55. doi: 10.1530/ERC-11-0082. Print 2011 Oct.

49.

Lowering apolipoprotein CIII delays onset of type 1 diabetes.

Holmberg R, Refai E, Höög A, Crooke RM, Graham M, Olivecrona G, Berggren PO, Juntti-Berggren L.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10685-9. doi: 10.1073/pnas.1019553108. Epub 2011 Jun 13.

50.

Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours.

Juhlin CC, Haglund F, Obara T, Arnold A, Larsson C, Höög A.

Virchows Arch. 2011 Jul;459(1):47-53. doi: 10.1007/s00428-010-1032-3. Epub 2011 Jan 8.

PMID:
21221636

Supplemental Content

Support Center